Shoulder Innovations
SI | NYSE
$20.45
-$0.24 (-1.16%)
At close: Nov 16, 2026, 4:00 PM ET
$20.45
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:00 PM ET
-1.16%
(1D)No price chart data available for 1D timeframe.
Rating
48.2
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #326/1021 (Top 32%)
Key Statistics
Market Data
Market Cap $427.86M
1D Range
20.30 21.10
52W Range
12.25 24.25
Valuation (TTM)
PE -12.62
PB 3.61
EV/EBITDA -11.06
Valuation (NTM)
Forward PE N/A
Forward PEG 0.61
Price Target $27.50
Cash Flow
FCF Yield -10.0%
SBC Adj. FCF Yield -10.7%
SBC Impact -7.5%
Margins
Gross Margin 77.8%
Operating Margin -54.4%
FCF Margin -66.2%
Growth (CAGR)
Revenue 3Y | 5Y 73.1% |
N/A
Dil EPS 3Y | 5Y -32.6% |
N/A
FCF 3Y | 5Y N/A |
N/A
Returns
ROA -22.9%
ROE -25.8%
ROIC -26.3%
Financial Health
Net Cash
$77.45M
Current Ratio 10.68
Interest Coverage 34.19
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered ...
Sector Healthcare
Industry Medical - Specialties
Employees 74
IPO Date Jul 31, 2025
Website www.shoulderinnovations.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.34
Beat +30.72%
YoY:
+29.17% REV
$16.19M
Beat +2.42%
YoY:
+37.73%Next Earnings
Mar 9, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$27.50
Upside
+34.47%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SI